These studies indicated that IL-1β and miR-200c-3p expression was markedly elevated in colonic tissue and epithelial cells from patients with ulcerative colitis and also suggested the possibility that miR-200c-3p may be targeted to inhibit the IL-1β-associated increase in intestinal TJ permeability and treat intestinal inflammation. Here, IL1B is linked to gastroenteritis.